Skip to content

Investigation and comparison of two treatment protocols based on transcranial direct current stimulation (Tdcs) and treatment based on acceptance and commitment (ACT) on reducing the intensity of pain, anxiety and depression in patients with rheumatoid arthritis.

Investigation and comparison of two treatment protocols based on transcranial direct current stimulation (Tdcs) and treatment based on acceptance and commitment (ACT) on reducing the intensity of pain, anxiety and depression in patients with rheumatoid arthritis.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240629062274N1
Enrollment
60
Registered
2024-07-01
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rheumatoid arthritis.

Interventions

Intervention group: 3 intervention groups,Two groups of transcranial direct electrical stimulation and one treatment group based on acceptance and commitment..

Sponsors

Khoram-Abad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: The people assigned to the groups must have the entry criteria, which include: having a history of one year of treatment under the supervision of a rheumatic disease specialist and having a medical record, not having a mental disorder and not abusing drugs and drug addiction, the desire to Participation in research.

Exclusion criteria

Exclusion criteria: Exclusion criteria for participants: medical diseases in the last 6 months, cardiovascular diseases, use of illegal drugs in the last 30 days, psychotic disorder, bipolar disorder, clinically significant suicidal thoughts, previous seizures, current pregnancy, attempt to Being pregnant, current breastfeeding, active alcohol use disorder, metal in the head, implanted electromedical device, brain injury with loss of consciousness longer than five minutes, and previous exposure to tdcs.

Design outcomes

Primary

MeasureTime frame
Reduction Chronic pain will be determined by the participant's score on the McGill Pain Questionnaire. Timepoint: Assessment in the pre-test - after the intervention and once a month after the intervention in the follow-up period. Method of measurement: McGill pain questionnaire and visual pain scale.;Reduction depression. Timepoint: Assessment in the pre-test - after the intervention and once a month after the intervention in the follow-up period. Method of measurement: It will be measured through the person's score in the Beck depression test.;Reduction anxiety. Timepoint: Assessment in the pre-test - after the intervention and once a month after the intervention in the follow-up period. Method of measurement: The score that the participant will get in the Beck anxiety test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFiruzeh Ghazanfari

Khoram-Abad University of Medical Sciences

Firoozeh.ghazanfari@yahoo.com+98 21 7709 1533

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026